-
DPP-4 Inhibitors for the Treatment of Parkinson’s Disease (Supplement)
… inhibitor sitagliptin in PD by defining a drug dose and a systemic biomarker of central incretin actions. Sitagliptin …
-
Katie Hood Appointed Chief Executive Officer of The Michael J. Fox Foundation
December 14, 2007
… innovative funding mechanisms to work to change a flawed system that too often fails to translate research into …
-
Michael J. Fox Foundation Awards $1.9 Million to Support Ceregene Phase Ii Gene Therapy Clinical Trial
October 10, 2006
… which uses a vector to deliver neurturin, a potent nervous system trophic factor, has shown potential in preclinical …
-
Michael J. Fox Foundation Seeks Novel Drug Development Strategies for 2007 Target Validation Initiative
October 14, 2006
… effects of manipulating that target in relevant PD model systems, is required to move research along. These …
-
Get Moving: Exercising for a Healthy Brain
May 18, 2023
… by adding a password. Your information is already in our system. Login here to register. Register Thank you for your …
-
CSF RT-QuIC Alpha-Synuclein Amplification in LRRK2-Parkinson’s Disease
… reflecting the LRRK2-PD’s variable effects on the nervous system. We expect that in a reduced number of people without …
Animations
Your search for “Multiple System Atrophy” returned 2623 results.